LobbyingAssociation for Diagnostics & Laboratory Medicine lobbying by quarter
Association for Diagnostics & Laboratory Medicine's latest lobbying report covers Q2 2026, at $120K. The four quarters Q3 2025–Q2 2026 total $320K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.
Association for Diagnostics & Laboratory Medicine
- Latest quarter
- $120K
- Q2 2026 · 1 reports
- Last 12 months
- $320K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $160K | 1 |
| Q1 2023 | $70K | 1 |
| Q2 2023 | $170K | 1 |
| Q3 2023 | $70K | 1 |
| Q4 2023 | $160K | 1 |
| Q1 2024 | $50K | 1 |
| Q2 2024 | $140K | 1 |
| Q3 2024 | $60K | 1 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $130K | 1 |
| Q2 2025 | $150K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $120K | 1 |
| Q2 2026 | $120K | 1 |
Policy issues the reports name
- Budget and appropriations15 reports
- Medical research and clinical labs12 reports
- Health issues5 reports
- Medicare and Medicaid3 reports
- Government issues1 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Health & Human Services, Dept of (HHS)5 reports
- Centers For Disease Control & Prevention (CDC)2 reports
- Office of Management & Budget (OMB)2 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Food & Drug Administration (FDA)1 reports
- Homeland Security, Dept of (DHS)1 reports
- Natl Institutes of Health (NIH)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAssociation for Diagnostics & Laboratory Medicine | $1.5M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | In-house | $120K |
| 04/15for Q1 | In-house | $120K |
| 01/09for Q4 2025 | In-house | $40K |
| 25/10/27for Q3 2025 | In-house | $40K |
| 25/07/11for Q2 2025 | In-house | $150K |
| 25/04/16for Q1 2025 | In-house | $130K |
| 25/01/08for Q4 2024 | In-house | $60K |
| 24/10/16for Q3 2024 | In-house | $60K |
| 24/08/15for Q2 2024 | In-house | $140K |
| 24/04/10 | In-house | Under $5,000 |
| 24/04/10for Q1 2024 | In-house | $50K |
| 24/01/18for Q4 2023 | In-house | $160K |
| 23/10/16for Q3 2023 | In-house | $70K |
| 23/07/14for Q2 2023 | In-house | $170K |
| 23/04/11for Q1 2023 | In-house | $70K |
| 23/01/06for Q4 2022 | In-house | $160K |